Effect of carbidopa, entacapone and levodopa at bed time on sleep quality in Parkinson's disease compared to levodopa and carbidopa-CR

被引：0

|

作者：

Ma, H. I.

Baik, J. S.

Kang, S. Y.

Kim, J. W.

Kim, Y. J.

机构：

来源：

MOVEMENT DISORDERS | 2012年 / 27卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

678

引用

收藏

页码：S219 / S219

页数：1

相关论文

共 50 条

[21] Combined levodopa carbidopa with Entacapone improves the motor complications in advanced Parkinson's disease
Ali, Md Ashraf
MOVEMENT DISORDERS, 2016, 31 : S27 - S27
[22] Frequent doses of levodopa/carbidopa/entacapone (Stalevo®) are associated with an improved levodopa plasma profile compared with traditional levodopa/carbidopa in healthy volunteers
Hanninen, J.
Korpela, K.
Kailajarvi, M.
Ruokoniemi, P.
Kuoppamaki, M.
Ellmen, J.
MOVEMENT DISORDERS, 2007, 22 : S87 - S87
[23] Levodopa/carbidopa/entacapone for the treatment of early Parkinson's disease: a meta-analysis
Liao, Xiaoli
Wu, Nianyue
Liu, Dongfeng
Shuai, Bowei
Li, Shilei
Li, Ke
NEUROLOGICAL SCIENCES, 2020, 41 (08) : 2045 - 2054
[24] A randomized, double-blind study to compare the effect on quality of life of levodopa/carbidopa/entacapone (Stalevo®) with levodopa/carbidopa in patients with Parkinson's disease with no or minimal, nondisabling motor fluctuations
Fung, V. S.
MOVEMENT DISORDERS, 2006, 21 : S446 - S446
[25] Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference
Mueller, Thomas
PATIENT PREFERENCE AND ADHERENCE, 2009, 3 : 51 - 59
[26] TRIPLE COMBINATION OF LEVODOPA, CARBIDOPA AND ENTACAPONE BY INTRAJEJUNAL PUMP IN ADVANCED PARKINSON'S DISEASE
Bertalan, Gyorfi
Botond, Balo
Krisztina, Botz
Jost, Wolfgang H.
IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2022, 75 (11-12): : 365 - 368
[27] Levodopa/carbidopa/entacapone for the treatment of early Parkinson’s disease: a meta-analysis
Xiaoli Liao
Nianyue Wu
Dongfeng Liu
Bowei Shuai
Shilei Li
Ke Li
Neurological Sciences, 2020, 41 : 2045 - 2054
[28] Comparison of 200 mg retarded release levodopa/carbidopa -: with 150 mg levodopa/carbidopa/entacapone application:: pharmacokinetics and efficacy in patients with Parkinson's disease
Mueller, T.
Ander, L.
Kolf, K.
Woitalla, D.
Muhlack, S.
JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (11) : 1457 - 1462
[29] Comparison of 200 mg retarded release levodopa/carbidopa – with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson’s disease
T. Müller
L. Ander
K. Kolf
D. Woitalla
S. Muhlack
Journal of Neural Transmission, 2007, 114 : 1457 - 1462
[30] Improved symptom control with fixed dose levodopa/carbidopa/entacapone versus conventional levodopa/carbidopa as first-line levodopa therapy in early Parkinson's disease patients
Hauser, R. A.
Panisset, M.
Abbruzzese, G.
Mancione, L.
Dronamraju, N.
Kakarieka, A.
MOVEMENT DISORDERS, 2008, 23 (01) : S208 - S208

← 1 2 3 4 5 →